Sections

Home | Cancers | Lung Cancer

Lung Cancer

Middle aged more likely to be diagnosed with advanced lung cancer

A lung cancer cell. image: http://www.cancerresearchuk.org/sites/default/files/styles/cruk_wide_resp_breakpoint_one/public/lungcancercellcrop-hero_0.jpg?itok=K5AiJW1- Read more at http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2016-06-14-middle-aged-more-likely-to-be-diagnosed-with-advanced-lung-cancer#xr6GbrOX1AAU8Zs1.99 Younger patients – aged 50 to 64 – are more likely to be diagnosed with ...

Sex hormones appear to be involved in the development of autism

Human social capabilities might be associated with genetic variations in sex hormone related genes. Such were the results of a new doctoral ...

Mobile-Friendly Web Application Extends Lung Cancer Survival

CHICAGO – A Web-mediated follow-up application (Moovcare™) improves advanced lung cancer survival, according to a French multicenter randomized phase III study. Researchers analyzed the association and ... Full story

Cancer researchers find up to one-quarter of lung cancer patients may be ineligible for immunotherapy

UT Southwestern cancer researchers Dr. Saad Khan, Dr. Sandi Pruitt, Dr. David Gerber, and Lei Xuan found that a significant proportion of lung cancer patients ... Full story

How Does Robotic Video-Assisted Thoracoscopic Surgery (RVATS) Compare to VATS for Treating Lung Cancer?

New Rochelle, NY —A new study shows that robotic video-assisted lung resection to remove a tumor achieves comparable outcomes with no significant differences in complications compared to conventional video-assisted thoracoscopic surgery (VATS), and robotic VATS (RVATS) may allow for preservation of more healthy lung tissue. ... Full story

'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds

A simple blood test can rapidly and accurately detect mutations in two key genes in non-small cell lung tumors, researchers at Dana-Farber Cancer Institute and other institutions report in a new study – demonstrating the test’s potential as a clinical tool for identifying patients who can benefit from drugs targeting those mutations. ... Full story

Newly discovered clues to the cause of chemoresistance in small cell lung cancer

(Vienna ) Small cell lung cancer is not usually detected until it is at an advanced stage, when metastases have already formed. Chemotherapy is very effective initially but, within a year, cancer recurs and this time does not respond to a course of chemotherapy. ... Full story

New Lung Cancer Therapy May Target Previously Untreatable Tumors

By Julie Grisham - Lung cancer is responsible for more deaths than any other cancer. Until now, lung cancer patients with mutations in a gene called KRAS have not benefited from developments in precision therapy. ... Full story

High-Risk Lung Cancer Patients May Not Need Annual Screenings

By Duke Medicine News and Communications - DURHAM, N.C. – Most high-risk lung cancer patients might not need annual low-dose computed tomography (LDCT) screenings if they are cleared of disease in their initial test, according to a study led by a Duke Cancer Institute researcher. ... Full story

Researchers find a new genetic target for most common lung cancer

Offers a potentially new way to differentiate and treat some patients with the disease ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 187 | displaying: 1 - 10